Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulationsGUERRA, P; FRIAS, J; RUIZ, B et al.Journal of clinical pharmacy and therapeutics (Print). 2001, Vol 26, Num 2, pp 113-119, issn 0269-4727Article

Facile and rapid high-performance liquid chromatography method for simultaneous determination of allopurinol and oxypurinol in human serumTADA, H; FUJISAKI, A; ITOH, K et al.Journal of clinical pharmacy and therapeutics (Print). 2003, Vol 28, Num 3, pp 229-234, issn 0269-4727, 6 p.Article

An Audit of a Therapeutic Drug Monitoring Service for Allopurinol TherapyKANNANGARA, Diluk R. W; RAMASAMY, Sheena N; RAY, John E et al.Therapeutic drug monitoring. 2013, Vol 35, Num 6, pp 863-866, issn 0163-4356, 4 p.Article

Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinolYAMAMOTO, Tetsuya; MORIWAKI, Yuji; TAKAHASHI, Sumio et al.Journal of rheumatology. 2001, Vol 28, Num 10, pp 2294-2297, issn 0315-162XArticle

Untersuchungen zur klinischen Pharmakokinetik von Allopurinol. I: Allopurinol-Absorptionsorte und Dosisproportionalität der Allopurinol/Oxipurinol-Bioverfügbarkeit = Etude sur la pharmacocinétique clinique de l'allopurinol. I: Communication: sites d'absorption de l'allopurinol et proportionnalité de l'allopurinol/oxipurinol, biodisponibilité = Studies on the clinical pharmacokinetics of allopurinol. I: Communication: Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailabilitySCHUSTER, O; HAERTEL, M; HUGEMANN, B et al.Arzneimittel-Forschung. 1985, Vol 35, Num 4, pp 760-765, issn 0004-4172Article

A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detectionREINDERS, Mattheus K; NIJDAM, Lars C; VAN ROON, Eric N et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 45, Num 2, pp 312-317, issn 0731-7085, 6 p.Article

Studies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose : In vitro and in vivoNIE, Shu-Fang; WEI LI; LIN LUAN et al.Drug development and industrial pharmacy. 2007, Vol 33, Num 9, pp 1024-1029, issn 0363-9045, 6 p.Article

Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjectsTURNHEIM, K; KRIVANEK, P; OBERBAUER, R et al.British journal of clinical pharmacology. 1999, Vol 48, Num 4, pp 501-509, issn 0306-5251Article

OXIPURINOL-ASSOCIATED INHIBITION OF PYRIMIDINE SYNTHESIS IN HUMAN LYMPHOBLASTS = INHIBITION ASSOCIEE A L'OXIPURINOL DE LA SYNTHESE DES PYRIMIDINES DANS LES LYMPHOBLASTES HUMAINSBECKER MA; ARGUBRIGHT KF; FOX RM et al.1974; MOLEC. PHARMACOL.; U.S.A.; DA. 1974; VOL. 10; NO 4; PP. 657-668; BIBL. 34REF.Article

Allopurinol and oxypurinol are hydroxyl radical scavengersMOORHOUSE, P. C; GROOTVELD, M; HALLIWELL, B et al.FEBS letters. 1987, Vol 213, Num 1, pp 23-28, issn 0014-5793Article

Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinolDAY, Richard O; GRAHAM, Garry G; HICKS, Mark et al.Clinical pharmacokinetics. 2007, Vol 46, Num 8, pp 623-644, issn 0312-5963, 22 p.Article

Allopurinol kinetics in humans as a means to assess liver function: design of a loading testVAN WAEG, G; GROTH, T.American journal of physiology. Regulatory, integrative and comparative physiology. 1989, Vol 26, Num 1, pp R237-R245, issn 0363-6119Article

Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromeroneCOLIN, J. N; FARINOTTI, R; FREDJ, G et al.European journal of clinical pharmacology. 1986, Vol 31, Num 1, pp 53-58, issn 0031-6970Article

DIE WIRKUNGSGERECHTE ANWENDUNG VON ALLOPURINOL IN DER LANGZEITBEHANDLUNG = L'EMPLOI DE L'ALLOPURINOL A ACTION CALCULEE PENDANT LE TRAITEMENT PROLONGEFENNER H.1980; FORTSCHR. D. MED.; DEU; DA. 1980; VOL. 98; NO 10; PP. 373-376; BIBL. 10 REF.Article

ABSENCE OF CHROMOSOME DAMAGE IN HUMAN LYMPHOCYTES EXPOSED TO ALLOPURINOL AND OXIPURINOL. IN VIVO AND IN VITRO STUDIES = ABSENCE DE LESION DES CHROMOSOMES DANS LES LYMPHOCYTES HUMAINS EXPOSES A L'ALLOPURINOL ET A L'OXYPURINOL. ETUDE IN VIVO ET IN VITROSTEVENSON AC; SILCOCK SR; SCOTT JT et al.1976; ANN. RHEUMAT. DIS.; G.B.; DA. 1976; VOL. 35; NO 2; PP. 143-147; BIBL. 18 REF.Article

Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in miceZHEN TAN; TIEYING DAI; XIN ZHONG et al.European journal of pharmacology. 2009, Vol 621, Num 1-3, pp 71-77, issn 0014-2999, 7 p.Article

Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney diseaseKANNANGARA, Diluk R. W; ROBERTS, Darren M; FURLONG, Timothy J et al.British journal of clinical pharmacology. 2012, Vol 73, Num 5, pp 828-829, issn 0306-5251, 2 p.Article

Relationship Between Serum Urate and Plasma Oxypurinol in the Management of Gout: Determination of Minimum Plasma Oxypurinol Concentration to Achieve a Target Serum Urate LevelSTAMP, L. K; BARCLAY, M. L; O'DONNELL, J. L et al.Clinical pharmacology and therapeutics. 2011, Vol 90, Num 3, pp 392-398, issn 0009-9236, 7 p.Article

The effect of dietary protein on the clearance of allopurinol and oxypurinolBERLINGER, W. G; PARK, G. D; SPECTOR, R et al.The New England journal of medicine. 1985, Vol 313, Num 13, pp 771-776, issn 0028-4793Article

Protection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioningWILLIAMS, C. David; MCGILL, Mitchell R; LEBOFSKY, Margitta et al.Toxicology and applied pharmacology. 2014, Vol 274, Num 3, pp 417-424, issn 0041-008X, 8 p.Article

The population pharmacokinetics of allopurinol and oxypurinol in patients with goutWRIGHT, Daniel F. B; STAMP, Lisa K; MERRIMAN, Tony R et al.European journal of clinical pharmacology. 2013, Vol 69, Num 7, pp 1411-1421, issn 0031-6970, 11 p.Article

Oxidative and nitrosative stress in acute pancreatitis. Modulation by pentoxifylline and oxypurinolESCOBAR, Javier; PEREDA, Javier; JOOSTEN, Leo A. B et al.Biochemical pharmacology. 2012, Vol 83, Num 1, pp 122-130, issn 0006-2952, 9 p.Article

The pharmacokinetics of oxypurinol in people with goutSTOCKER, Sophie L; MCLACHLAN, Andrew J; SAVIC, Radojka M et al.British journal of clinical pharmacology. 2012, Vol 74, Num 3, pp 477-489, issn 0306-5251, 13 p.Article

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardiumKÖGLER, Harald; FRASER, Heather; MCCUNE, Sylvia et al.Cardiovascular research. 2003, Vol 59, Num 3, pp 582-592, issn 0008-6363, 11 p.Article

SIMULTANEOUS DETERMINATION OF ALLOPURINOL AND OXIPURINOL IN BIOLOGICAL FLUIDS BY MASS FRAGMENTOGRAPHYLARTIGUE MATTEI C; CHABARD JL; BARGNOUX H et al.1982; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1982; VOL. 229; NO 1; PP. 211-216; BIBL. 2 REF.Article